Table II.
SPOP expression | ||||
---|---|---|---|---|
Characteristic | N | Low | High | P-value |
Sex | 0.266 | |||
Male | 94 | 82 | 12 | |
Female | 63 | 50 | 13 | |
Age | 0.266 | |||
≤60 | 94 | 50 | 13 | |
>60 | 63 | 82 | 12 | |
Histologic type | 0.003a | |||
Adenocarcinoma | 115 | 91 | 24 | |
Squamous cell carcinoma | 42 | 41 | 1 | |
Tumor differentiation | 0.046a | |||
Well | 29 | 21 | 8 | |
Moderate | 100 | 84 | 16 | |
Poor | 28 | 27 | 1 | |
Tumor size | 0.0036a | |||
T1 | 83 | 69 | 14 | |
T2 | 62 | 56 | 6 | |
T3 | 7 | 4 | 3 | |
T4 | 5 | 2 | 3 | |
Lymph node metastasis | 0.041a | |||
Absent | 104 | 83 | 21 | |
Present | 53 | 49 | 4 | |
Lung cancer stages | 0.046a | |||
1 | 29 | 21 | 8 | |
2 | 100 | 84 | 16 | |
3 | 28 | 27 | 1 |
Statistically significant. SPOP, speckle-type POZ domain protein.